Detected ·
Orakl Oncology
$34MSeries A
Orakl Oncology, a Paris-based startup using AI and patient-derived tumour models to predict cancer drug performance, raised a $34M Series A co-led by Singular and Norrsken VC.
- Website
- www.orakl-oncology.com
- linkedin.com/company/85957194
- Amount
- $34 000 000 USD
- Stage
- Series A
- Event
- Funding round
- Detected
- 2026-11-12 14:08:41 UTC
- Signal ID
- 462d028f-baf7-483c-90d7-7a163eac646e
As the API returns it
{
"id": "462d028f-baf7-483c-90d7-7a163eac646e",
"created_at": "2026-11-12T14:08:41.380355Z",
"company_name": "Orakl Oncology",
"company_website_url": "www.orakl-oncology.com",
"company_linkedin_url": "https://www.linkedin.com/company/85957194",
"event_type": "funding",
"funding_amount": 34000000,
"funding_currency": "USD",
"funding_stage": "series_a",
"message": "*Orakl Oncology, a Paris-based startup using AI and patient-derived tumour models to predict cancer drug performance, raised a $34M Series A co-led by Singular and Norrsken VC.*"
}